Outcome of Neonates Born to COVID-Positive Women at 6 Months of Age
Indian Pediatrics
; 58(9):853-856, 2021.
Article
in English
| MEDLINE | ID: covidwho-1404466
ABSTRACT
OBJECTIVES:
To compare clinical and neurodevelopmental outcome at the age of 6 months for neonates born to SARS-CoV-2-positive mothers.METHODS:
Neonates of SARS-CoV-2 positive mothers, admitted in our hospital were assessed for growth, neurodevelopment by Amiel-Tison method, and Developmental Profile (DP3) at discharge as part of another study (July 2020). This data were retrieved and babies followed-up at the age of 6 months. Composite adverse outcome was death within 6 months post discharge or DP3 score <70 and hearing/visual deficit.RESULTS:
Out of 131 enrolled at discharge, 127 (97%) were followed up. SARs-CoV-2 positive neonates (Group I;19, 15%) had more symptoms (P=0.012), sepsis (P=0.014), pneumonia (P=0.029), longer hospital stay (P<0.001) following birth compared to group II (SARs-CoV-2 negative neonates;108, 85%). No baby in group I met definition of composite adverse outcome, while in group II it was 0.9% (1 child with DP3 <70 with hearing deficit) (P=1.0) without any difference in hospital readmission, growth, DP3 scores, or tone abnormalities.CONCLUSIONS:
There is no difference in growth, neurodevelopment, and hospital readmission in early infancy among infected and non-infected babies born to SARS-CoV-2 positive mothers.
Search on Google
Collection:
Databases of international organizations
Database:
MEDLINE
Type of study:
Prognostic study
Language:
English
Journal:
Indian Pediatrics
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS